research Network-Based Identification of Genetic Effect of SARS-CoV-2 Infections on Idiopathic Pulmonary Fibrosis Patients
SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.
Search
forLearn
0 / 0 results — no results
Research
5 / 44 results
research Cutaneous Alternariosis in a Patient with Idiopathic Pulmonary Fibrosis
A 78-year-old farmer with lung disease had skin lesions from a fungal infection that healed completely with medication.
research The Role of the Mammalian Target of Rapamycin in Pulmonary Fibrosis
mTOR inhibitors may help treat lung fibrosis.
research Novel Nanoparticulate Systems for Idiopathic Pulmonary Fibrosis: A Review
Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.
research Accelerated UIP: A Special Challenge
Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.
Community Join
0 / 0 results — no results